| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8211209 | International Journal of Radiation Oncology*Biology*Physics | 2018 | 22 Pages |
Abstract
MT affects survival. Risk factors include older age, male sex, multiple tumor locations, use of chemotherapy alone, and presence of residual disease. Our finding that initial interventions could affect the rate of MT is provocative, but these data should be validated using data from prospective trials. In addition to improving survival, future therapeutic efforts should focus on preventing MT.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Erin S. MD, Charles M. MD, Michael PhD, John H. MD, Samuel T. MD, Jennifer S. MD, PhD, Rupesh MD, Xuefei MS, David M. MD, Richard A. MD, MEd, Glen H.J. DO, PhD, Gene H. MD, MBA, Michael A. MD, PhD, Manmeet S. MD,